南模生物股价涨6.19%，天弘基金旗下1只基金位居十大流通股东，持有37.74万股浮盈赚取115.49万元

Group 1 - The core viewpoint of the news is that Nanmo Biological has experienced a significant stock price increase, rising 6.19% to 52.50 yuan per share, with a total market capitalization of 4.093 billion yuan and a cumulative increase of 13.26% over the past five days [1] - Nanmo Biological, established on September 20, 2000, specializes in the research, production, and sales of genetically modified animal models, with its main business revenue composition being: standardized models 48.34%, model technical services 21.92%, model breeding 19.50%, customized models 9.34%, and others 0.91% [1] Group 2 - Tianhong Medical Health A (001558) has entered the top ten circulating shareholders of Nanmo Biological, holding 377,400 shares, which accounts for 0.48% of the circulating shares, and has earned approximately 1.1549 million yuan in floating profit today [2] - The fund has achieved a year-to-date return of 14.09% and a one-year return of 55.87%, ranking 261 out of 8,838 and 1,806 out of 8,089 respectively [2]